These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nevada
|
83-4064262
|
|
(State
or other jurisdiction of incorporation or
organization)
|
(I.R.S.
Employer Identification No.)
|
|
Title
of Each Class
|
|
Trading
Symbol(s)
|
|
Name of
Each Exchange on Which Registered
|
|
Common
Stock, par value $.60 per share
|
|
BKTI
|
|
NYSE
American
|
|
Large
accelerated filer
|
☐
|
Accelerated
filer
|
☐
|
|
Non-accelerated
filer
|
☑
|
Smaller
reporting company
|
☑
|
|
|
|
Emerging
growth company
|
☐
|
|
|
March
31, 2020
|
December 31,
2019
|
|
|
(Unaudited)
|
|
|
ASSETS
|
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
4,946
|
$
4,676
|
|
Trade accounts
receivable, net
|
4,590
|
3,964
|
|
Inventories,
net
|
10,937
|
13,513
|
|
Prepaid expenses
and other current assets
|
1,802
|
1,733
|
|
Total current
assets
|
22,275
|
23,886
|
|
|
|
|
|
Property, plant and
equipment, net
|
3,775
|
3,964
|
|
Right-of-use (ROU)
asset
|
2,791
|
2,885
|
|
Investment in
securities
|
2,329
|
2,635
|
|
Deferred tax
assets, net
|
4,373
|
4,373
|
|
Other
assets
|
169
|
197
|
|
Total
assets
|
$
35,712
|
$
37,940
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$
4,836
|
$
5,310
|
|
Accrued
compensation and related taxes
|
1,045
|
1,271
|
|
Accrued warranty
expense
|
1,099
|
1,248
|
|
Accrued other
expenses and other current liabilities
|
402
|
479
|
|
Dividends
payable
|
250
|
252
|
|
Short-term lease
liability
|
393
|
369
|
|
Note
payable-current portion
|
78
|
78
|
|
Deferred
revenue
|
462
|
369
|
|
Total current
liabilities
|
8,565
|
9,376
|
|
|
|
|
|
Note payable, net
of current portion
|
309
|
328
|
|
Long-term lease
liability
|
2,511
|
2,606
|
|
Deferred
revenue
|
2,685
|
2,354
|
|
Total
liabilities
|
14,070
|
14,664
|
|
Commitments and
contingencies
|
|
|
|
Stockholders’
equity:
|
|
|
|
Preferred stock;
$1.00 par value; 1,000,000 authorized shares; none issued or
outstanding
|
—
|
—
|
|
Common stock; $.60
par value; 20,000,000 authorized shares; 13,929,381 issued and
12,495,110 and 12,596,923 outstanding shares at March 31, 2020 and
December 31, 2019, respectively
|
8,357
|
8,357
|
|
Additional paid-in
capital
|
26,146
|
26,095
|
|
Accumulated
deficit
|
(7,485
)
|
(6,043
)
|
|
Treasury stock, at
cost, 1,434,271 and 1,332,458 shares at March 31, 2020 and December
31, 2019, respectively
|
(5,376
)
|
(5,133
)
|
|
Total
stockholders’ equity
|
21,642
|
23,276
|
|
Total liabilities
and stockholders’ equity
|
$
35,712
|
$
37,940
|
|
|
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
|
|
|
|
Sales,
net
|
$
10,889
|
$
7,644
|
|
Expenses
|
|
|
|
Cost of
products
|
6,994
|
5,207
|
|
Selling, general
and administrative
|
4,743
|
4,755
|
|
Total
expenses
|
11,737
|
9,962
|
|
|
|
|
|
Operating
loss
|
(848
)
|
(2,318
)
|
|
|
|
|
|
Other (expense)
income:
|
|
|
|
Net interest
income
|
9
|
55
|
|
(Loss) gain on
investment in securities
|
(306
)
|
592
|
|
Other
expense
|
(47
)
|
(2
)
|
|
Total other
(expense) income
|
(344
)
|
645
|
|
|
|
|
|
Loss before income
taxes
|
(1,192
)
|
(1,673
)
|
|
|
|
|
|
Income tax
benefit
|
—
|
355
|
|
|
|
|
|
Net
loss
|
$
(1,192
)
|
$
(1,318
)
|
|
|
|
|
|
Net loss per
share-basic and diluted:
|
$
(0.09
)
|
$
(0.10
)
|
|
Weighted average
shares outstanding-basic
|
12,555,108
|
12,761,713
|
|
Weighted average
shares outstanding-diluted
|
12,555,108
|
12,761,713
|
|
|
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
Operating
activities
|
|
|
|
Net
loss
|
$
(1,192
)
|
$
(1,318
)
|
|
Adjustments to
reconcile net loss to net cash provided by (used in) operating
activities:
|
|
|
|
Inventories
allowances
|
38
|
19
|
|
Deferred tax
benefit
|
—
|
(355
)
|
|
Depreciation and
amortization
|
320
|
256
|
|
Share-based
compensation expense
|
30
|
31
|
|
Restricted stock
unit compensation expense
|
21
|
41
|
|
(Gain) loss on
investment in securities
|
306
|
(592
)
|
|
Changes in
operating assets and liabilities:
|
|
|
|
Trade accounts
receivable
|
(626
)
|
676
|
|
Inventories
|
2,538
|
(715
)
|
|
Prepaid expenses
and other current assets
|
(69
)
|
(143
)
|
|
Other
assets
|
28
|
1
|
|
Lease
liability
|
23
|
—
|
|
Accounts
payable
|
(474
)
|
602
|
|
Accrued
compensation and related taxes
|
(226
)
|
(951
)
|
|
Accrued warranty
expense
|
(149
)
|
(88
)
|
|
Deferred
revenue
|
424
|
296
|
|
Accrued other
expenses and other current liabilities
|
(77
)
|
(68
)
|
|
Net
cash provided by (used in) operating activities
|
915
|
(2,308
)
|
|
|
|
|
|
Investing
activities
|
|
|
|
Purchases of
property, plant and equipment
|
(131
)
|
(829
)
|
|
Net
cash used in investing activities
|
(131
)
|
(829
)
|
|
|
|
|
|
Financing
activities
|
|
|
|
Cash dividends
paid
|
(252
)
|
(256
)
|
|
(243
)
|
(337
)
|
|
|
Proceeds from
issuance of common stock
|
—
|
2
|
|
Repayment of
debt
|
(19
)
|
—
|
|
Net
cash used in financing activities
|
(514
)
|
(591
)
|
|
|
|
|
|
Net change in cash
and cash equivalents
|
270
|
(3,728
)
|
|
Cash and cash
equivalents, beginning of period
|
4,676
|
11,268
|
|
Cash and cash
equivalents, end of period
|
$
4,946
|
$
7,540
|
|
|
|
|
|
Supplemental
disclosure
|
|
|
|
Cash paid for
interest
|
$
5
|
$
—
|
|
|
March
31, 2020
|
December 31,
2019
|
|
Finished
goods
|
$
2,680
|
$
3,864
|
|
Work in
process
|
4,725
|
6,122
|
|
Raw
materials
|
3,532
|
3,527
|
|
|
$
10,937
|
$
13,513
|
|
|
Common
Stock Shares
|
Common
Stock Amount
|
Additional
Paid-In Capital
|
Accumulated
Deficit
|
Treasury
Stock
|
Total
|
|
Balance at December
31, 2018
|
13,882,937
|
$
8,330
|
$
25,867
|
$
(2,393
)
|
$
(4,092
)
|
$
27,712
|
|
Stock options
exercised and issued
|
1,000
|
—
|
2
|
—
|
—
|
2
|
|
Share-based
compensation expense
|
—
|
—
|
31
|
—
|
—
|
31
|
|
Restricted stock
unit compensation expense
|
—
|
—
|
41
|
—
|
—
|
41
|
|
Dividends declared
($0.02
per share)
|
—
|
—
|
—
|
(254
)
|
—
|
(254
)
|
|
Net
loss
|
—
|
—
|
—
|
(1,318
)
|
—
|
(1,318
)
|
|
Repurchase of
common stock
|
—
|
—
|
—
|
—
|
(337
)
|
(337
)
|
|
Balance at March
31, 2019
|
13,883,937
|
$
8,330
|
$
25,941
|
$
(3,965
)
|
$
(4,429
)
|
$
25,877
|
|
|
Common
Stock Shares
|
Common
Stock Amount
|
Additional
Paid-In Capital
|
Accumulated
Deficit
|
Treasury
Stock
|
Total
|
|
Balance at December
31, 2019
|
13,929,381
|
$
8,357
|
$
26,095
|
$
(6,043
)
|
$
(5,133
)
|
$
23,276
|
|
Share-based
compensation expense
|
—
|
—
|
30
|
—
|
—
|
30
|
|
Restricted stock
unit compensation expense
|
—
|
—
|
21
|
—
|
—
|
21
|
|
Dividends declared
($0.02
per share)
|
—
|
—
|
—
|
(250
)
|
—
|
(250
)
|
|
Net
loss
|
—
|
—
|
—
|
(1,192
)
|
—
|
(1,192
)
|
|
Repurchase of
common stock
|
—
|
—
|
—
|
—
|
(243
)
|
(243
)
|
|
Balance at March
31, 2020
|
13,929,381
|
$
8,357
|
$
26,146
|
$
(7,485
)
|
$
(5,376
)
|
$
21,642
|
|
|
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
Numerator:
|
|
|
|
Net loss (numerator
for basic and diluted loss per share)
|
$
(1,192
)
|
$
(1,318
)
|
|
Denominator:
|
|
|
|
Denominator for
basic loss per share weighted average shares
|
12,555,108
|
12,761,713
|
|
Effect of dilutive
securities:
|
|
|
|
Options and
restricted stock units
|
—
|
—
|
|
Denominator:
|
|
|
|
Denominator for
diluted loss per share weighted average shares
|
12,555,108
|
12,761,713
|
|
Basic loss per
share
|
$
(0.09
)
|
$
(0.10
)
|
|
Diluted loss per
share
|
$
(0.09
)
|
$
(0.10
)
|
|
As of
January 1, 2020
|
Stock
Options
|
Wgt.
Avg.
Exercise
Price
($)
Per
Share
|
Wgt.
Avg.
Remaining
Contractual
Life
(Years)
|
Wgt.
Avg.
Grant
Date
Fair Value
($)
Per
Share
|
Aggregate
Intrinsic
Value
($)
|
|
Outstanding
|
569,500
|
4.16
|
6.82
|
1.75
|
24,000
|
|
Vested
|
214,800
|
4.12
|
4.20
|
1.95
|
24,000
|
|
Nonvested
|
354,700
|
4.18
|
8.40
|
1.63
|
—
|
|
|
|
|
|
|
|
|
Period
activity
|
|
|
|
|
|
|
Issued
|
—
|
—
|
—
|
—
|
—
|
|
Exercised
|
—
|
—
|
—
|
—
|
—
|
|
Forfeited
|
56,100
|
4.11
|
—
|
1.74
|
—
|
|
Expired
|
65,000
|
4.07
|
—
|
2.88
|
—
|
|
|
|
|
|
|
|
|
As
of March 31, 2020
|
|
|
|
|
|
|
Outstanding
|
448,400
|
4.18
|
7.34
|
1.59
|
—
|
|
Vested
|
201,400
|
4.21
|
6.22
|
1.55
|
—
|
|
Nonvested
|
247,000
|
4.15
|
8.26
|
1.62
|
—
|
|
|
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
Operating lease
cost
|
$
143
|
$
134
|
|
Short-term lease
cost
|
2
|
4
|
|
Variable lease
cost
|
32
|
32
|
|
Total lease
cost
|
$
177
|
$
170
|
|
|
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
Cash paid for
amounts included in the measurement of lease
liabilities:
|
|
|
|
Operating cash
flows (fixed payments)
|
$
122
|
$
118
|
|
Operating cash
flows (liability reduction)
|
82
|
78
|
|
|
|
|
|
ROU assets obtained
in exchange for lease obligations:
|
|
|
|
Operating
leases
|
9
|
2,840
|
|
|
March
31, 2020
|
|
Weighted average
remaining lease term (in years)
|
6.81
|
|
Weighted average
discount rate
|
5.50
%
|
|
|
March 31, 2020
|
|
Remaining
nine months of 2020
|
$
541
|
|
2021
|
526
|
|
2022
|
444
|
|
2023
|
451
|
|
2024
|
461
|
|
Thereafter
|
1,074
|
|
Total
payments
|
3,497
|
|
Less:
imputed interest
|
593
|
|
Total
liability
|
$
2,904
|
|
|
Percentage
of Sales
Three
Months Ended
|
|
|
|
March
31, 2020
|
March 31,
2019
|
|
Sales
|
100.0
%
|
100.0
%
|
|
Cost of
products
|
(64.2
)
|
(68.1
)
|
|
Gross
margin
|
35.8
|
31.9
|
|
Selling, general
and administrative expenses
|
(43.6
)
|
(62.2
)
|
|
Other (expense)
income
|
(3.2
)
|
8.4
|
|
Loss before income
taxes
|
(11.0
)
|
(21.9
)
|
|
Income tax
benefit
|
—
|
4.7
|
|
Net
loss
|
(11.0
)%
|
(17.2
)%
|
|
Period
|
Total Number of Shares Purchased
|
Average Price Paid Per Share (1)
|
Total Number of Shares Purchased as Part of Publicly Announced
Plans or Programs (2)
|
Maximum Number of Shares that May Yet Be Purchased Under Publicly
Announced Plans or Programs (2)
|
|
01/01/20-01/31/20
|
36,155
|
$
2.94
|
36,155
|
81,787
|
|
02/01/20-02/29/20
|
20,963
|
$
2.72
|
20,963
|
60,824
|
|
03/01/20-03/31/20
|
44,695
|
$
1.72
|
44,695
|
16,129
|
|
Total
|
101,813
|
$
2.36
|
101,813
|
|
|
Exhibit
Number
|
|
Description
|
|
|
Articles
of Merger, filed with the Nevada Secretary of State on March 28,
2019 (Incorporated by reference from Exhibit 3.1 to the
Company’s Current Report on Form 8-K12B filed March 28,
2019)
|
|
|
|
Articles
of Incorporation of BK Technologies Corporation (Incorporated by
reference from Exhibit 3.2 to the Company’s Current Report on
Form 8-K12B filed March 28, 2019)
|
|
|
|
Bylaws
of BK Technologies Corporation (Incorporated by reference from
Exhibit 3.3 to the Company’s Current Report on Form 8-K12B
filed March 28, 2019)
|
|
|
|
Credit
Agreement, executed as of January 30, 2020, by and between JPMorgan
Chase Bank, N.A., as lender, and BK Technologies, Inc., as borrower
(Incorporated by reference from Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed January 30, 2020)
|
|
|
|
Line of Credit Note, executed as of January 30, 2020, by BK
Technologies, Inc., as borrower, for the benefit of JPMorgan Chase
Bank, N.A., as lender (Incorporated by reference from Exhibit
10.2 to the Company’s Current Report on Form 8-K filed
January 30, 2020)
|
|
|
|
Continuing
Guaranty, executed as of January 30, 2020, by and among JPMorgan
Chase Bank, N.A., as lender, and BK Technologies Corporation and
RELM Communications, Inc., as guarantors (Incorporated by reference
from Exhibit 10.3 to the Company’s Current Report on Form 8-K
filed January 30, 2020)
|
|
|
|
Continuing Security Agreement, executed as of January 30, 2020, by
and between JPMorgan Chase Bank, N.A., as lender, and BK
Technologies, Inc., as pledgor (Incorporated by reference from
Exhibit 10.4 to the Company’s Current Report on Form 8-K
filed January 30, 2020)
|
|
|
|
Certification
of Principal Executive Officer Pursuant to Item 601(b)(31) of
Regulation S-K, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
|
|
Certification
of Principal Financial Officer Pursuant to Item 601(b)(31) of
Regulation S-K, as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
|
|
Certification
of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (furnished pursuant to Item 601(b)(32) of Regulation
S-K)
|
|
|
|
Certification
of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (furnished pursuant to Item 601(b)(32) of Regulation
S-K)
|
|
|
Exhibit
101.INS
|
|
XBRL
Instance Document
|
|
Exhibit
101.SCH
|
|
XBRL
Taxonomy Extension Schema Document
|
|
Exhibit
101.CAL
|
|
XBRL
Taxonomy Extension Calculation Linkbase Document
|
|
Exhibit
101.LAB
|
|
XBRL
Taxonomy Extension Label Linkbase Document
|
|
Exhibit
101.PRE
|
|
XBRL
Taxonomy Extension Presentation Linkbase Document
|
|
Exhibit
101.DEF
|
|
XBRL
Taxonomy Definition Linkbase Document
|
|
|
BK TECHNOLOGIES CORPORATION
|
|
|
(The “Registrant”)
|
|
|
|
|
Date:
May 13, 2020
|
By:
/s/
Timothy A.
Vitou
|
|
|
Timothy
A. Vitou
President
(Principal
executive officer and duly
authorized
officer)
|
|
|
|
|
Date:
May 13, 2020
|
By:
/s/
William P.
Kelly
|
|
|
William
P. Kelly
Executive Vice
President and
Chief
Financial Officer
(Principal
financial and accounting
officer
and duly authorized officer)
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|